GKB Ophthalmics Peer Comparison
NSE: GKB | BSE: 533212
₹60.09
As on 12-Oct-2026IST
Market cap
₹30 Cr
Revenue (TTM)
₹150 Cr
P/E Ratio
9.3
P/B Ratio
0.6
Div. Yield
0 %
| GKB Ophthalmics | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
30 | 50,812 | 7,528 | 1,080 | 66 |
Revenue (₹ Cr) |
150 | 6,725 | 7,229 | 287 | 21 |
Net Profit (₹ Cr) |
5.63 | 1,128.79 | 210.43 | 28.67 | 3.24 |
Net Margin (%) |
3.69 | 16.02 | 2.88 | 9.68 | 15.18 |
RoE (%) |
6.65 | 11.51 | 11.02 | 9.14 | 19.12 |
Price to Earnings |
9.29 | 45.01 | 35.77 | 34.97 | 20.27 |
Price-To-Book |
0.55 | 4.78 | 3.76 | 4.40 | 3.53 |
Income Statement (₹ Cr)
| GKB Ophthalmics | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Operating Revenue
|
149.06 | 6,430.65 | 6,892.47 | 277.86 | 16.80 |
|
Total Income
|
151.31 | 6,746.98 | 6,963.79 | 286.40 | 16.93 |
|
Total Expenditure
|
140.44 | 4,801.11 | 6,268.09 | 233.97 | 14.47 |
|
EBITDA
|
8.62 | 1,629.54 | 624.38 | 43.89 | 2.34 |
|
Depreciation
|
3.24 | 423.67 | 282.87 | 15.88 | 0.81 |
|
EBIT
|
5.38 | 1,205.88 | 341.51 | 28.02 | 1.53 |
|
Interest
|
2.67 | 33.28 | 137.50 | 1.86 | 0.61 |
|
Other Income
|
2.24 | 316.33 | 71.32 | 8.55 | 0.12 |
|
Exceptional Items
|
-1.79 | -24.35 | -- | -5.78 | -- |
|
Profit before Tax
|
3.10 | 1,464.58 | 275.33 | 28.93 | 1.04 |
|
Provision for Tax
|
0.08 | 437.26 | 55.72 | 2.50 | 0.29 |
|
Profit after Tax
|
3.03 | 1,027.32 | 219.61 | 26.43 | 0.75 |
Liabilities (₹ Cr)
| GKB Ophthalmics | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
52.83 | 10,357.95 | 1,975.36 | 243.32 | 13.78 |
|
Minority Interest
|
2.05 | -- | -0.71 | 0.79 | 0.00 |
|
Non-Current Liabilities
|
10.02 | 482.17 | 1,225.00 | 14.83 | -0.07 |
|
Current Liabilities
|
71.19 | 1,608.40 | 763.90 | 30.79 | 8.87 |
|
Total Liabilities
|
136.09 | 12,448.52 | 4,084.80 | 300.10 | 23.05 |
Assets (₹ Cr)
| GKB Ophthalmics | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
28.13 | 4,921.74 | 1,820.29 | 101.01 | 5.39 |
|
Current Assets
|
107.96 | 7,526.79 | 2,143.26 | 188.72 | 17.19 |
|
Total Assets
|
136.09 | 12,448.52 | 4,084.80 | 300.10 | 23.05 |
|
Total Debt*
|
11.66 | 243.36 | 0.00 | 0.00 | 5.07 |
|
Net Current Assets
|
36.77 | 5,918.38 | 1,379.36 | 157.93 | 8.32 |
|
Contingent Liabilities
|
8.97 | 10.12 | 14.06 | -- | 0.42 |
Cashflow (₹ Cr)
| GKB Ophthalmics | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-3.81 | 1,031.39 | 495.58 | -5.00 | -0.01 |
|
Cash Flow from Investing Activities
|
9.00 | 137.73 | -127.72 | -79.58 | -0.04 |
|
Cash from Financing Activities
|
-5.55 | -416.97 | -255.51 | -17.75 | 0.19 |
|
Net Cash Inflow / Outflow
|
-0.35 | 752.14 | 112.36 | -102.33 | 0.14 |
Ratios
Profitability Ratios
| GKB Ophthalmics | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
ROCE (%)
|
8.82 | 14.96 | 22.22 | 13.29 | 9.13 |
|
ROE (%)
|
5.77 | 10.56 | 11.93 | 11.95 | 5.59 |
|
ROA (%)
|
2.28 | 8.70 | 6.00 | 9.31 | 3.42 |
|
EBIT Margin (%)
|
7.29 | 30.26 | 10.09 | 18.87 | 14.64 |
|
Net Margin (%)
|
2.00 | 15.23 | 3.15 | 9.23 | 4.43 |
|
Cash Profit Margin (%)
|
4.20 | 22.56 | 7.19 | 15.23 | 9.27 |
Growth Ratios
| GKB Ophthalmics | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
36.77 | 14.50 | 12.33 | 16.21 | -23.76 |
|
EBIT Growth (%)
|
848.46 | 31.25 | 26.01 | 14.03 | -59.17 |
|
Net Profit Growth (%)
|
142.76 | 47.07 | 46.18 | 4.16 | -77.67 |
|
EPS Growth (%)
|
117.30 | 47.07 | 45.68 | -8.79 | -77.67 |
|
Book Value Growth (%)
|
1.53 | 12.70 | 14.76 | 14.31 | 5.75 |
Valuation Ratios
| GKB Ophthalmics | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Price / Earnings
|
21.72 | 27.22 | 45.79 | 29.86 | 29.91 |
|
Price / Book Value
|
0.50 | 2.71 | 5.11 | 3.67 | 1.63 |
|
Dividend Yield (%)
|
0.00 | 1.18 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
3.06 | 12.77 | 13.79 | 16.32 | 10.73 |
|
Market Cap (₹ Cr)
|
26.46 | 27,964.97 | 10,057.49 | 865.33 | 22.43 |
Solvency Ratios
| GKB Ophthalmics | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.22 | 0.02 | 0.00 | 0.00 | 0.37 |
|
Short term debt to equity ratio
|
0.14 | -- | -- | -- | 0.33 |
|
Current Ratio
|
1.52 | 4.68 | 2.81 | 6.13 | 1.94 |
|
Quick Ratio
|
0.75 | 3.60 | 1.00 | 5.42 | 1.15 |
|
Interest Coverage
|
2.16 | 45.01 | 3.00 | 16.57 | 2.71 |
Operating Efficiency Ratios
| GKB Ophthalmics | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
30.10 | 29.41 | 0.39 | 16.39 | 39.46 |
|
Asset Turnover
|
1.12 | 0.54 | 1.91 | 0.98 | 0.77 |
|
Receivable days
|
86.14 | 96.72 | 1.05 | 54.00 | 122.59 |
|
Inventory Days
|
128.56 | 97.32 | 71.25 | 26.54 | 138.71 |
|
Payable days
|
165.50 | 134.60 | 21.75 | 94.91 | 36.89 |
|
Cash Conversion Cycle
|
49.21 | 59.43 | 50.55 | -14.37 | 224.42 |